15 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... Active TB: • ... and Culture • CXR ... Treatment: Active ... • Check CXR and
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... Active TB: • ... and Culture • CXR ... Treatment: Active ... • Check CXR and
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Microbiologically Confirmed Pulmonary ... Tuberculosis - ... #ActiveTB #RIPE ... #medications #pharmacology ... #Treatment
Pott's Disease in Tuberculosis - Diagnosis and Management Summary
Epidemiology:
 - Typically from TB endemic areas
 -
Pott's Disease in ... extrapulmonary cases Clinical ... signs/symptoms of active ... pulmonary TB PE ... tissue damage - CXR
Tuberculosis Testing

LATENT TB
• LTBI is diagnosed when an asymptomatic patient has a positive TST or IGRA
LATENT TB • ... result with no clinical ... IGRA/QuantiFERON-TB ... intermediate risk of disease ... used to exclude pulmonary
Tuberculin Skin Test Interpretation - Threshold for treatment
Induration cutoff >5mm:
 • Recent exposure to an individual
Threshold for treatment ... individual with active ... CXR consistent ... with old TB disease ... individuals #Tuberculosis
Nontuberculous mycobacteria
Nontuberculous mycobacteria, also known as atypical mycobacteria, are all the other mycobacteria which can cause
which can cause pulmonary ... TB. ... a patient with active ... #Clinical #Radiology ... #CXR #Lateral #
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... disease who are ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... TB Disease: • ... HIV-infected persons with clinical ... #TB #IDSA #Prevention ... infections #HIVAIDS #pharmacology
Primairy TB is usually clinically silent.
In 5% of infected individuals the immunity is inadequate and clinically
clinically silent ... active disease ... progressive primary disease ... On the CXR it is ... #CXR #Tuberculosis